-
ESTIMATING THE COST-EFFECTIVENESS OF SPARSENTAN RELATIVE TO REAL-WORLD RENIN-ANGIOTENSIN SYSTEMINHIBITION STANDARD OF CARE FOR IMMUNOGLOBULIN A NEPHROPATHY: A PATIENT-LEVEL MICROSIMULATION
Mar 18, 2026, 21:38 PM -
AN INDIRECT TREATMENT COMPARISON (ITC) OF IFINATAMAB DERUXTECAN (I-DXD) VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY (RWPCT) IN PATIENTS PREVIOUSLY TREATED WITH AT LEAST 2 LINES OF THERAPY (LOTS) FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER...
Mar 18, 2026, 21:38 PM -
REAL-WORLD OUTCOMES OF SECOND-LINE THERAPIES IN RELAPSED/REFRACTORY DLBCL PATIENTS IN GERMANY: IMPACT OF FRONT-LINE TREATMENT-FREE PERIOD (2020-2022)
Mar 18, 2026, 21:38 PM -
LEVERAGING HEALTH INSURANCE DATA FOR ACCELERATED AND TARGETED RECRUITMENT IN CLINICAL TRIALS IN GERMANY
Mar 18, 2026, 21:38 PM -
IMPACT OF ETEPLIRSEN TREATMENT INITIATION DELAYS ON LOSS OF AMBULATION INCIDENCE AMONG AMBULATORY PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AMONG PEOPLE WITH MODERATE-TO-SEVERE HEMOPHILIA A AND B IN CHINA: A RETROSPECTIVE DATABASE STUDY
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF AN AI-ENABLED DIGITAL TWIN INTERVENTION IN TYPE 2 DIABETES
Mar 18, 2026, 21:38 PM -
EARLY EXPERIENCE WITH THE EUROPEAN UNION JOINT CLINICAL ASSESSMENT (EUJCA): IMPLICATIONS FOR ONCOLOGY PRODUCTS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF UBLITUXIMAB FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS
Mar 18, 2026, 21:38 PM -
A SNAPSHOT ASSESSMENT OF THE IMPLEMENTATION OF BROADER VALUE ELEMENTS IN ECONOMIC EVALUATIONS: FROM GUIDANCE TO PRACTICE
Mar 18, 2026, 21:38 PM -
THE SAFETY AND EFFECTIVENESS OF STERILE HYPOCHLOROUS ACID USED AS SURGICAL IRRIGATION SOLUTION TO REDUCE POSTOPERATIVE COMPLICATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
HOW HAVE ECONOMIC EVALUATIONS EVALUATED UNCERTAINTY IN POLYGENIC RISK SCORES?: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF METABOLIC SYNDROME IN SCHIZOPHRENIA: A CLAIMS-BASED ANALYSIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD CTDNA TEST UTILIZATION AND ASSOCIATED COSTS IN US PATIENTS WITH BLADDER CANCER WHO UNDERWENT RADICAL CYSTECTOMY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF SAVOLITINIB VERSUS GLUMETINIB IN THE FIRST-LINE TREATMENT OF CHINESE ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER HARBORING MET EXON 14 SKIPPING MUTATION
Mar 18, 2026, 21:38 PM -
REAL-WORLD FUNCTIONAL, ECONOMIC, AND BEHAVIORAL BURDEN OF ACUTE GLUTEN EXPOSURE IN U.S. ADULTS WITH CELIAC DISEASE: INSIGHTS FROM A LARGE NATIONAL COHORT
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF THRUST CHUNA MANUAL THERAPY COMPARED WITH NON-THRUST CHUNA OR USUAL CARE IN PATIENTS WITH NON-ACUTE LOW BACK PAIN
Mar 18, 2026, 21:38 PM -
TREATMENT DELAYS IN IBD: A MULTI-SITE REAL-WORLD ANALYSIS ACROSS UC HEALTH
Mar 18, 2026, 21:38 PM -
VALIDATION OF A TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) UNITED STATES (US) CLAIMS-BASED CODING ALGORITHM
Mar 18, 2026, 21:38 PM -
VALUE-BASED DECISION BOUNDARIES ANALYSIS (VB-DBA): A NOVEL METHOD OF INTEGRATING NETWORK META-ANALYSIS AND COST-EFFECTIVENESS MODELLING TO ESTIMATE PRICING THRESHOLDS BASED ON TARGET PRODUCT PROFILES
Mar 18, 2026, 21:38 PM
